PALATIN TECHNOLOGIES INC
PTNDrugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How PTN's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Bremelanotide | Phase 3 | Kidney Disease | - | - |
PL3994 | Phase 2 | Hypertension | - | - |
PL8177 | Phase 2 | Ulcerative Colitis | - | - |
Frequently asked questions
What is in PALATIN TECHNOLOGIES INC's drug pipeline?→
CatalystAlert tracks 3 drug candidates in PALATIN TECHNOLOGIES INC's (PTN) pipeline across Phase 3, Phase 2. Its lead program is Bremelanotide (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PALATIN TECHNOLOGIES INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for PALATIN TECHNOLOGIES INC (PTN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PTN biotech catalysts?→
Add PTN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PALATIN TECHNOLOGIES INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.